Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
KellyASAuerbachPBarrientos-PerezMGiesIHalePMMarcusCet alA randomized, controlled trial of liraglutide for adolescents with obesity
men should report severe abdominal pain or persistent vomiting to their clinician promptly
Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment
Assessment of requirements for selenium and adequacy of selenium status: A review
